{"id":339137,"date":"2026-11-04T13:59:00","date_gmt":"2026-11-04T08:29:00","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=339137"},"modified":"2026-11-04T13:59:00","modified_gmt":"2026-11-04T08:29:00","slug":"largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/","title":{"rendered":"4 Largecap One-Year Winners With High Profit CAGR Stocks to Watch for Future Multibagger Potential: Shriram Finance, Torrent Pharma, BSE and BHEL"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Shriram Finance Rs 884.80. Torrent Pharma Rs 4,650. BSE Rs 3,665.70. BHEL Rs 400. Market caps from Rs 1.52 lakh crore to Rs 2.19 lakh crore. Data as of 3 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Shriram Finance, Torrent Pharma, BSE and BHEL are the 4 picks in this one-year winners with high profit CAGR stocks watchlist, with market caps between Rs 1.52 lakh crore and Rs 2.19 lakh crore. Shriram Finance stands out for the lowest PE of the group at 19.38, while Torrent Pharma offers 20.34% revenue growth in FY26. PE ratios run from 19.38 to 81.87, so compare each one with its industry PE before investing. All figures are as of 3 November 2026.<\/p>\n<\/p><\/div>\n<p>One-year winners with high profit CAGR stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Shriram Finance, Torrent Pharma, BSE and BHEL meet that test, with market caps from Rs 1.52 lakh crore to Rs 2.19 lakh crore and Shriram Finance offering the lowest PE of the group at 19.38. Each of these companies has a one-year share price return of at least 25 per cent and a four year profit CAGR of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.<\/p>\n<p>This list covers companies with a one-year share price return of at least 25 per cent and a four year profit CAGR of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening one-year winners with high profit CAGR stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 3 November 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=one-year-winners-with-high-profit-cagr-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#What_Are_One-Year_Winners_With_High_Profit_CAGR_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are One-Year Winners With High Profit CAGR Stocks and Why Do They Attract Multibagger Interest?\">What Are One-Year Winners With High Profit CAGR Stocks and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#One-Year_Winners_With_High_Profit_CAGR_Stocks_at_a_Glance_Price_Market_Cap_PE_ROE_and_Price_to_Book\" title=\"One-Year Winners With High Profit CAGR Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book\">One-Year Winners With High Profit CAGR Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#Shriram_Finance_3864_Profit_CAGR_Since_FY22\" title=\"Shriram Finance: 38.64% Profit CAGR Since FY22\">Shriram Finance: 38.64% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#Torrent_Pharma_2879_Profit_CAGR_Since_FY22\" title=\"Torrent Pharma: 28.79% Profit CAGR Since FY22\">Torrent Pharma: 28.79% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#BSE_7830_Profit_CAGR_Since_FY22\" title=\"BSE: 78.30% Profit CAGR Since FY22\">BSE: 78.30% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#BHEL_3773_Profit_CAGR_Since_FY22\" title=\"BHEL: 37.73% Profit CAGR Since FY22\">BHEL: 37.73% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#One-Year_Winners_With_High_Profit_CAGR_Stocks_Financial_Comparison_on_Growth_and_Margins\" title=\"One-Year Winners With High Profit CAGR Stocks: Financial Comparison on Growth and Margins\">One-Year Winners With High Profit CAGR Stocks: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#Institutional_Holding_in_Shriram_Finance_Torrent_Pharma_BSE_and_BHEL\" title=\"Institutional Holding in Shriram Finance, Torrent Pharma, BSE and BHEL\">Institutional Holding in Shriram Finance, Torrent Pharma, BSE and BHEL<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#Risks_to_Weigh_in_One-Year_Winners_With_High_Profit_CAGR_Stocks\" title=\"Risks to Weigh in One-Year Winners With High Profit CAGR Stocks\">Risks to Weigh in One-Year Winners With High Profit CAGR Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#How_to_Choose_Between_One-Year_Winners_With_High_Profit_CAGR_Stocks\" title=\"How to Choose Between One-Year Winners With High Profit CAGR Stocks\">How to Choose Between One-Year Winners With High Profit CAGR Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_One-Year_Winners_With_High_Profit_CAGR_Stocks_to_Watch\" title=\"Frequently Asked Questions on One-Year Winners With High Profit CAGR Stocks to Watch\">Frequently Asked Questions on One-Year Winners With High Profit CAGR Stocks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#Which_are_the_best_one-year_winners_with_high_profit_CAGR_stocks_to_watch_for_multibagger_potential\" title=\"Which are the best one-year winners with high profit CAGR stocks to watch for multibagger potential?\">Which are the best one-year winners with high profit CAGR stocks to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#Is_BSE_a_good_stock_for_long-term_investors\" title=\"Is BSE a good stock for long-term investors?\">Is BSE a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#Can_Shriram_Finance_become_a_multibagger_from_here\" title=\"Can Shriram Finance become a multibagger from here?\">Can Shriram Finance become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Shriram_Finance_Torrent_Pharma_BSE_and_BHEL\" title=\"What is the market cap of Shriram Finance, Torrent Pharma, BSE and BHEL?\">What is the market cap of Shriram Finance, Torrent Pharma, BSE and BHEL?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_one-year_winners_with_high_profit_CAGR_stocks\" title=\"What are the risks of investing in one-year winners with high profit CAGR stocks?\">What are the risks of investing in one-year winners with high profit CAGR stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#Why_is_Torrent_Pharma_trading_at_a_PE_of_8187\" title=\"Why is Torrent Pharma trading at a PE of 81.87?\">Why is Torrent Pharma trading at a PE of 81.87?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Shriram_Finance_Torrent_Pharma_BSE_and_BHEL\" title=\"How much do institutions hold in Shriram Finance, Torrent Pharma, BSE and BHEL?\">How much do institutions hold in Shriram Finance, Torrent Pharma, BSE and BHEL?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_One-Year_Winners_With_High_Profit_CAGR_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are One-Year Winners With High Profit CAGR Stocks and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>One-year winners with high profit CAGR stocks are shares of large companies that have gained at least a quarter in value over the last year and whose profit has compounded at fifteen per cent or more a year from FY22 to FY26. The four here cover vehicle finance, pharmaceuticals, stock exchange services and heavy electrical equipment.<\/p>\n<p>A strong one year run shows that the market has noticed the business, and four years of compounding profit shows that the rise rests on a steady earnings record and not on a single good year. Within one-year winners with high profit CAGR stocks, the four companies show rising profit. For one-year winners with high profit CAGR stocks, both FY26 and the latest quarter showed growth. Whichever way you read one-year winners with high profit CAGR stocks, the common thread is rising profit backed by complete financial data. Investors researching one-year winners with high profit CAGR stocks get a fuller picture by reading growth and valuation together. The table below lines up one-year winners with high profit CAGR stocks on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use one-year winners with high profit CAGR stocks as a starting point for your own research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"One-Year_Winners_With_High_Profit_CAGR_Stocks_at_a_Glance_Price_Market_Cap_PE_ROE_and_Price_to_Book\"><\/span><strong>One-Year Winners With High Profit CAGR Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 3 November 2026. Shriram Finance has the lowest PE of the group at 19.38, while BSE posts the highest return on equity at 37.42%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Price to Book<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/shriramfin\/shriram-finance-ltd-share-price-today\">Shriram Finance<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">884.80<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,19,317<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19.38<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.68<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.21%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2.08<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">662.25 to 1,153.70<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\">Torrent Pharmaceuticals<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,650<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,76,513<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">81.87<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">25.49%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.99<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,480.60 to 5,250.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/bse\/bse-ltd-share-price-today\">BSE Ltd<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,665.70<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,56,983<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">55.63<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">42.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">37.42%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.52<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,326.10 to 4,446.80<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/bhel\/bharat-heavy-electricals-ltd-share-price-today\">Bharat Heavy Electricals<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">400<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,51,782<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">52.70<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">45.89<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.76%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.68<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">229.54 to 464.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Shriram_Finance_3864_Profit_CAGR_Since_FY22\"><\/span><strong>Shriram Finance: 38.64% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Shriram Finance is a major NBFC focused on commercial vehicle, small business and personal loans. It reported FY26 total income of Rs 48,192.65 crore, up 15.13% year on year, and net profit of Rs 10,004.20 crore, up 6.16%. Net profit has compounded at 38.64% a year since FY22, while total income has grown 25.75% a year.<\/p>\n<p>In the June 2026 quarter, total income rose 16.26% to Rs 13,418.74 crore and net profit grew 59.95% to Rs 3,447.26 crore. The share price has gained 239.61% over five years and 40.91% over the past year. Domestic institutions raised their holding from 18.66% in September 2025 to 19.90% in June 2026. The stock trades at a PE of 19.38 against an industry PE of 17.68, with a return on equity of 15.21%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Torrent_Pharma_2879_Profit_CAGR_Since_FY22\"><\/span><strong>Torrent Pharma: 28.79% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Torrent Pharmaceuticals makes branded medicines for chronic therapies such as cardiac, gastro-intestinal and central nervous system care in India and overseas. It reported FY26 revenue of Rs 13,886.15 crore, up 20.34% year on year, and net profit of Rs 2,138.18 crore, up 11.87%. Net profit has compounded at 28.79% a year since FY22, while revenue has grown 12.38% a year. Operating margin was 22.70% in FY26.<\/p>\n<p>The stock trades at a PE of 81.87 against an industry PE of 36.42, with a return on equity of 25.49%. In the June 2026 quarter, revenue rose 56.29% to Rs 4,909 crore and net profit grew 3.28% to Rs 566 crore. The share price has gained 194.63% over five years and 29.72% over the past year. Domestic institutions raised their holding from 9.28% in September 2025 to 12.87% in July 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"BSE_7830_Profit_CAGR_Since_FY22\"><\/span><strong>BSE: 78.30% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>BSE Ltd operates one of India&#8217;s two major stock exchanges and earns from trading, listing, data and clearing services. It reported FY26 revenue of Rs 5,148.10 crore, up 59.07% year on year, and net profit of Rs 2,475.30 crore, up 87.94%. Net profit has compounded at 78.30% a year since FY22, while revenue has grown 56.26% a year. Operating margin was 68.39% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 63.41% to Rs 1,706.72 crore and net profit grew 62.15% to Rs 872.66 crore. The share price has gained 2101.66% over five years and 37.49% over the past year. Domestic institutions raised their holding from 13.51% in June 2025 to 24.15% in June 2026. The stock trades at a PE of 55.63 against an industry PE of 42.42, with a return on equity of 37.42%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"BHEL_3773_Profit_CAGR_Since_FY22\"><\/span><strong>BHEL: 37.73% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bharat Heavy Electricals is a government-owned maker of power generation, transmission, industrial and transportation equipment. It reported FY26 revenue of Rs 34,589.83 crore, up 20.08% year on year, and net profit of Rs 1,600.26 crore, up 199.73%. Net profit has compounded at 37.73% a year since FY22, while revenue has grown 12.54% a year. Operating margin was 10.18% in FY26. The debt-to-equity ratio is 0.23.<\/p>\n<p>The stock trades at a PE of 52.70 against an industry PE of 45.89. In the September 2026 quarter, revenue rose 24.28% to Rs 9,553.01 crore and net profit grew 118.98% to Rs 820.94 crore. The share price has gained 488.34% over five years and 86.13% over the past year. Domestic institutions raised their holding from 18.62% in September 2025 to 21.88% in September 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"One-Year_Winners_With_High_Profit_CAGR_Stocks_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>One-Year Winners With High Profit CAGR Stocks: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these one-year winners with high profit CAGR stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Total Income (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Income Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Income CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Net Profit CAGR<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Shriram Finance<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">48,192.65<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10,004.20<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.13%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">25.75%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">38.64%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Torrent Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13,886.15<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,138.18<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.34%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.38%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">28.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">BSE<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5,148.10<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,475.30<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">59.07%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">56.26%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">78.30%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">BHEL<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34,589.83<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,600.26<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.08%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.54%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">37.73%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these one-year winners with high profit CAGR stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Shriram_Finance_Torrent_Pharma_BSE_and_BHEL\"><\/span><strong>Institutional Holding in Shriram Finance, Torrent Pharma, BSE and BHEL<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these one-year winners with high profit CAGR stocks alongside the promoter. The table uses the latest reported quarter for each. Shriram Finance has the deepest institutional backing, with FII and DII together holding 74.67% as of June 2026. Domestic institutions increased their holding over the past year in Shriram Finance (from 18.66% to 19.90%), Torrent Pharma (from 9.28% to 12.87%), BSE (from 13.51% to 24.15%) and BHEL (from 18.62% to 21.88%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Shriram Finance<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.30%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">54.77%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19.90%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.04%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Torrent Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">60.78%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.97%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.87%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8.38%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">July 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">BSE<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Nil<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.32%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.15%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">54.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">BHEL<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">58.17%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.94%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.88%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.02%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_One-Year_Winners_With_High_Profit_CAGR_Stocks\"><\/span><strong>Risks to Weigh in One-Year Winners With High Profit CAGR Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with one-year winners with high profit CAGR stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> Torrent Pharma trades at a PE of 81.87 against an industry PE of 36.42, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_One-Year_Winners_With_High_Profit_CAGR_Stocks\"><\/span><strong>How to Choose Between One-Year Winners With High Profit CAGR Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from one-year winners with high profit CAGR stocks comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check asset quality and net interest margin first, then return on equity and price to book. Debt-to-equity does not apply to lenders.<\/li>\n<li>Compare each PE with the industry PE (17.68 to 45.89) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Shriram Finance, Torrent Pharma, BSE and BHEL live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among one-year winners with high profit CAGR stocks, Shriram Finance stands out for the lowest PE of the group at 19.38, Torrent Pharma for 20.34% revenue growth in FY26, BSE for the highest return on equity at 37.42% and BHEL for the strongest latest-quarter profit growth at 118.98%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing one-year winners with high profit CAGR stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_One-Year_Winners_With_High_Profit_CAGR_Stocks_to_Watch\"><\/span><strong>Frequently Asked Questions on One-Year Winners With High Profit CAGR Stocks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_one-year_winners_with_high_profit_CAGR_stocks_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best one-year winners with high profit CAGR stocks to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Shriram Finance, Torrent Pharma, BSE and BHEL are the 4 names this list highlights, with market caps of Rs 2,19,317 crore, Rs 1,76,513 crore, Rs 1,56,983 crore and Rs 1,51,782 crore respectively. Shriram Finance is notable for the lowest PE of the group at 19.38. Torrent Pharma stands out for 20.34% revenue growth in FY26. BSE offers the highest return on equity at 37.42%. BHEL brings the strongest latest-quarter profit growth at 118.98%. These are watchlist names for one-year winners with high profit CAGR stocks, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_BSE_a_good_stock_for_long-term_investors\"><\/span><strong>Is BSE a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> BSE has a return on equity of 37.42%, a PE of 55.63 against an industry PE of 42.42 and a market cap of Rs 1,56,983 crore. Net profit has compounded at 78.30% a year since FY22, and FY26 revenue rose 59.07% while June 2026 quarter net profit grew 62.15%. Long-term returns in one-year winners with high profit CAGR stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Shriram_Finance_become_a_multibagger_from_here\"><\/span><strong>Can Shriram Finance become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Shriram Finance has already gained 239.61% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in one-year winners with high profit CAGR stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 38.64% a year since FY22, and FY26 revenue rose 15.13%. At a PE of 19.38 against an industry PE of 17.68, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Shriram_Finance_Torrent_Pharma_BSE_and_BHEL\"><\/span><strong>What is the market cap of Shriram Finance, Torrent Pharma, BSE and BHEL?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 3 November 2026, Shriram Finance has a market cap of Rs 2,19,317 crore, Torrent Pharma has a market cap of Rs 1,76,513 crore, BSE has a market cap of Rs 1,56,983 crore and BHEL has a market cap of Rs 1,51,782 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on one-year winners with high profit CAGR stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_one-year_winners_with_high_profit_CAGR_stocks\"><\/span><strong>What are the risks of investing in one-year winners with high profit CAGR stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Torrent Pharma trades at a PE of 81.87 against an industry PE of 36.42, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Torrent_Pharma_trading_at_a_PE_of_8187\"><\/span><strong>Why is Torrent Pharma trading at a PE of 81.87?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Torrent Pharma&#8217;s PE of 81.87 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 25.49%, profit growth of 28.79% a year since FY22 and FY26 revenue growth of 20.34%, which also means the stock is more sensitive if growth slows. Investors in one-year winners with high profit CAGR stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Shriram_Finance_Torrent_Pharma_BSE_and_BHEL\"><\/span><strong>How much do institutions hold in Shriram Finance, Torrent Pharma, BSE and BHEL?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 74.67% of Shriram Finance (54.77% and 19.90%), 30.84% of Torrent Pharma (17.97% and 12.87%), 45.47% of BSE (21.32% and 24.15%) and 31.82% of BHEL (9.94% and 21.88%). Rising institutional holding is a useful signal in one-year winners with high profit CAGR stocks, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best one-year winners with high profit CAGR stocks to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Shriram Finance, Torrent Pharma, BSE and BHEL are the 4 names this list highlights, with market caps of Rs 2,19,317 crore, Rs 1,76,513 crore, Rs 1,56,983 crore and Rs 1,51,782 crore respectively. Shriram Finance is notable for the lowest PE of the group at 19.38. Torrent Pharma stands out for 20.34% revenue growth in FY26. BSE offers the highest return on equity at 37.42%. BHEL brings the strongest latest-quarter profit growth at 118.98%. These are watchlist names for one-year winners with high profit CAGR stocks, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is BSE a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"BSE has a return on equity of 37.42%, a PE of 55.63 against an industry PE of 42.42 and a market cap of Rs 1,56,983 crore. Net profit has compounded at 78.30% a year since FY22, and FY26 revenue rose 59.07% while June 2026 quarter net profit grew 62.15%. Long-term returns in one-year winners with high profit CAGR stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Shriram Finance become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Shriram Finance has already gained 239.61% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in one-year winners with high profit CAGR stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 38.64% a year since FY22, and FY26 revenue rose 15.13%. At a PE of 19.38 against an industry PE of 17.68, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Shriram Finance, Torrent Pharma, BSE and BHEL?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 3 November 2026, Shriram Finance has a market cap of Rs 2,19,317 crore, Torrent Pharma has a market cap of Rs 1,76,513 crore, BSE has a market cap of Rs 1,56,983 crore and BHEL has a market cap of Rs 1,51,782 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on one-year winners with high profit CAGR stocks.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in one-year winners with high profit CAGR stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Torrent Pharma trades at a PE of 81.87 against an industry PE of 36.42, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Torrent Pharma trading at a PE of 81.87?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Torrent Pharma's PE of 81.87 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 25.49%, profit growth of 28.79% a year since FY22 and FY26 revenue growth of 20.34%, which also means the stock is more sensitive if growth slows. Investors in one-year winners with high profit CAGR stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Shriram Finance, Torrent Pharma, BSE and BHEL?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 74.67% of Shriram Finance (54.77% and 19.90%), 30.84% of Torrent Pharma (17.97% and 12.87%), 45.47% of BSE (21.32% and 24.15%) and 31.82% of BHEL (9.94% and 21.88%). Rising institutional holding is a useful signal in one-year winners with high profit CAGR stocks, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 largecap one-year winners with high profit CAGR stocks compared on market cap, PE, ROE, growth and institutional holding: Shriram Finance, Torrent Pharma, BSE and BHEL.<\/p>\n","protected":false},"author":33,"featured_media":339136,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[20006,20005],"class_list":["post-339137","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-one-year-winners-with-high-profit-cagr-sector","tag-one-year-winners-with-high-profit-cagr-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["339136"],"rank_math_title":["One-Year Winners With High Profit CAGR Stocks to Watch in 2026"],"rank_math_description":["One-year winners with high profit CAGR stocks to watch for multibagger potential: Shriram Finance, Torrent Pharma, BSE and BHEL. Compare market cap, PE, ROE and growth."],"rank_math_focus_keyword":["one-year winners with high profit CAGR stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/4-largecap-one-year-winners-with-high-profit-cagr-stocks-to-watch-for-future.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/339137","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=339137"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/339137\/revisions"}],"predecessor-version":[{"id":339138,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/339137\/revisions\/339138"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/339136"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=339137"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=339137"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=339137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}